Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 8Gastrointestinal 3Dermatologic 3Sarcoma 2Head & Neck 2Gynecologic 2Breast 2Tumor-Agnostic 1Thoracic 1Lymphoid 1

Conditions

Thyroid Diseases 1Laryngeal Neoplasms 1Adenolymphoma 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Fluorescein × Head & Neck × Clear all
NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Completed
8 enrolled 9 charts
Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

NCT02628496 2016-09-09

Confocal Laser Microlaryngoscopy (CLMx)

Washington University School of Medicine

Phase NA Withdrawn
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡